Literature DB >> 31388261

Assessment of Normative Range and Deriving Cut-Off Values for Lupus Anticoagulant Testing: An Experience from a Tertiary Care Center in Southern India.

Arikrishnan Ramaraj1, Vir Singh Negi2, Rakhee Kar1.   

Abstract

Lupus anticoagulant (LA) testing is a demanding laboratory test. The most common among recommended tests for LA are dilute Russell viper venom time (dRVVT) and LA sensitive activated partial thromboplastin time (LA-aPTT). Although integrated test systems come with manufacturer assigned cut-off, but according to guidelines cut-off should be locally-derived. This study was carried out to find normative range of LA using LA-aPTT and dRV VT tests in south Indian population (n = 100) and using locally derived cut-off values to interpret patient samples (n = 152) in a one-year study period. Cut-off (mean+2.3 SD) for aPTT, LA-aPTT, dRVVT screen and dRVVT confirm assays were 37.5, 45.7, 45.5 and 41.3 s and for normalized ratio and percentage correction of ratio were 1.16 and 15.8% respectively. Among patients, 25 (16.4%) were positive of whom 14 were positive by normalized ratio, seven by LA-aPTT and four were positive by both. Four additional patients could be identified using local cut-off. While the specificity of all screening tests was high, sensitivity of only dRVVT screen was high. All testing laboratories should attempt to derive normative range and locally-derived cut-off. While dRVVT is a good screening test with high sensitivity, however combining LA-aPTT offers advantage of picking up cases negative by dRVVT.

Entities:  

Keywords:  Cut-off; LA-aPTT; Locally-derived; Lupus anticoagulant; Normalized ratio; Normative range; dRVVT

Year:  2019        PMID: 31388261      PMCID: PMC6646615          DOI: 10.1007/s12288-019-01079-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  4 in total

1.  The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant.

Authors:  C Gardiner; I J MacKie; R G Malia; D W Jones; M Winter; D Leeming; D A Taberner; S J Machin; M Greaves
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

Review 2.  Guidelines on the investigation and management of antiphospholipid syndrome.

Authors:  David Keeling; Ian Mackie; Gary W Moore; Ian A Greer; Michael Greaves
Journal:  Br J Haematol       Date:  2012-02-08       Impact factor: 6.998

3.  Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

Authors:  V Pengo; A Tripodi; G Reber; J H Rand; T L Ortel; M Galli; P G De Groot
Journal:  J Thromb Haemost       Date:  2009-07-17       Impact factor: 5.824

4.  Recent guidelines and recommendations for laboratory detection of lupus anticoagulants.

Authors:  Gary W Moore
Journal:  Semin Thromb Hemost       Date:  2014-02-05       Impact factor: 4.180

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.